New criticism of EFSA
CRIIGEN, 19 October 2010
A new critical review has been published about the definite scientific shortcomings of regulatory committees, such as EFSA, in relation to the health risk assessment of edible GMOs.
The critical review in question was recently published in the International Journal of Biological Sciences and was signed by a CRIIGEN's group coordinated by Prof. Seralini.
It is a detailed answer to Monsanto, and to a number of website comments from various national committees which have approved Monsanto GMOs, in relation to a previous CRIIGEN study highlighting kidney and liver toxicity signs after the consumption of commercial GMOs.
All these GMOs do enhance the presence of new pesticide residues in food. The scientific reasons for the crucially different biological interpretations of admitted significant effects are presented in our paper, which highlights the shortcomings in the experimental protocols designed by the company and that were nonetheless accepted by authorities.
For instance, only 40 rats had blood analyses among 80 eating GMOs out of a total of 400; these experiments only lasted three months, whereas the assessment of a worldwide consumption for a population during its whole life is at stake.
Such a context implies a huge responsibility towards public health, especially since the traceability or epidemiological studies do not exist in the GMO-producing countries. In fact, this paper questions the independence of regulatory committees.
de Vendomois JS, Cellier D, Vélot C, Clair E, Mesnage R, Seralini GE. Debate on GMOs Health Risks after Statistical Findings in Regulatory Tests. Int J Biol Sci 2010; 6(6):590-598.